Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.
about
sameAs
Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysisHead injury at early ages is associated with risk of Parkinson's diseaseParkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicityRole of microglia in central nervous system infectionsEarly environmental origins of neurodegenerative disease in later life.Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunctionHuman neural progenitor cell engraftment increases neurogenesis and microglial recruitment in the brain of rats with strokePhysical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National RegistriesGene-environment interactions: key to unraveling the mystery of Parkinson's diseaseOccupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (Review)Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductanceRotenone and paraquat do not directly activate microglia or induce inflammatory cytokine releaseBrain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicitySex differences and effects of estrogenic compounds on the expression of inflammatory molecules by astrocytes exposed to the insecticide dimethoateSynergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia.Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia NigraNeuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic interventionMolecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.Air pollution & the brain: Subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative diseaseSubpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases.Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration.Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox.Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies.Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater SeverityNeuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling.Manganese chloride stimulates rat microglia to release hydrogen peroxideNeurochemical targets and behavioral effects of organohalogen compounds: an update.Gene-environment interactions in sporadic Parkinson's disease.Novel Molecular Insights into Classical and Alternative Activation States of Microglia as Revealed by Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based ProteomicsModulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.Genes and the environment in neurodegeneration.Substantia nigra depigmentation and exposure to encephalitis lethargica.Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionNanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.Common patterns of bcl-2 family gene expression in two traumatic brain injury models.CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease.The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.
P2860
Q22241651-AFB805BB-F7BF-495B-9F4E-D0EBCEC8D3F1Q24170146-6DE3E796-B92E-4CDE-9E41-6C53C1633FAFQ24296667-BF3A461B-20A0-4275-A7FC-22C098F028CAQ24563024-AB60351D-94A3-4F82-B25D-7CA70EFE2528Q24815631-8EC06788-BF51-417F-BF91-0AAC84FBA35AQ26849699-12A064A7-5289-45AC-84C8-732E8C38A26DQ27334229-3DC78D4B-05E3-4530-9D94-C414A8FA0745Q28386898-8FCC559E-8E01-4BCE-8E14-CCE513CA2C11Q28388674-950BDC00-BB20-4F02-B6FE-D3D48F6A2D07Q28389743-15CD93E7-2CE5-4532-B849-BBB5A49E94EEQ28392011-0B6BC819-79DD-424D-B62C-2ECC184A3108Q28392767-451C5F66-6FF3-45FF-9DD7-6145552C75FBQ28394667-21010F5A-D66A-4A6E-8747-4F32036E5718Q28570210-E137A3D9-C93A-4BAE-BF6E-FC72D9940F3AQ33601778-6F0EE70F-C7CA-4D47-95BB-5BB4D3A04CBAQ33646907-F377DBC0-8819-484A-B974-0A83B40AE2F3Q33663970-9EB5BA8B-7899-43B5-BF12-2FD566DCAE6DQ34142918-E300C31B-65E1-4C76-914F-6329020BCD19Q34210401-579D33CF-7E29-4840-BE5C-275402B2F510Q34381164-518498B5-6117-405B-824B-75FF1BF2D6CAQ34508284-216D71D8-F227-4EDB-90C2-FDC99ADFF8C8Q34615988-D2A8885F-F954-41EF-90F5-371A99D4D9D4Q34933261-70A8ED9F-5322-4B78-9317-D5F962381E9CQ35490451-E7A47045-E0B3-4C35-9359-B19BD7AEFD35Q35658761-B7886F02-B69A-4325-BF02-F8E7A1608AC5Q35884977-1285DCF5-FC15-4240-B463-444216E4D7EDQ35995995-431B876C-38BA-4C22-81D8-01F47A2CE3BCQ36156573-9702C268-D253-4EFD-971B-C871EF115AD0Q36178038-3D653F5B-84E9-4388-A08B-AF9338B963D2Q36473995-21CD9413-2928-4AB1-8E7B-9D1CD039D914Q36521952-80379BD5-B9DA-488C-9122-9A9DBE16089BQ36604409-C2AECFA2-3880-4821-A802-28673FF8C674Q36616362-1315EEBE-256D-4560-B8B9-F83D78957279Q36617960-783D6C82-94AB-4E13-9C5D-2111FD6E643CQ36862597-02C2B3F6-AE73-4BF0-A9E0-48814381D13DQ36919403-65CF0ABA-E18D-4DE3-BE40-F4489CC11829Q36968109-E9EFB685-3F2C-4C62-9E58-91F4926FC29FQ36990329-6A269DEA-8560-4355-8B2F-0CE2290C336DQ37015556-F98667DB-6F08-483B-B336-94B73381FEDBQ37076726-53F60ACB-F33B-4D62-9975-A526F90A51A1
P2860
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Parkinson's disease and exposu ...... ies: role of neuroinflammation
@nl
Parkinson's disease and exposu ...... es: role of neuroinflammation.
@ast
Parkinson's disease and exposu ...... es: role of neuroinflammation.
@en
type
label
Parkinson's disease and exposu ...... ies: role of neuroinflammation
@nl
Parkinson's disease and exposu ...... es: role of neuroinflammation.
@ast
Parkinson's disease and exposu ...... es: role of neuroinflammation.
@en
prefLabel
Parkinson's disease and exposu ...... ies: role of neuroinflammation
@nl
Parkinson's disease and exposu ...... es: role of neuroinflammation.
@ast
Parkinson's disease and exposu ...... es: role of neuroinflammation.
@en
P2093
P2860
P921
P3181
P356
P1476
Parkinson's disease and exposu ...... es: role of neuroinflammation.
@en
P2093
Hui-Ming Gao
Jau-Shyong Hong
P2860
P304
P3181
P356
10.1289/EHP.6361
P407
P577
2003-06-01T00:00:00Z